The IPKat

FEBRUARY 21, 2022

As many of our readers know one of the most recurrent tax-related topics that come into discussion in the IP field is the so-called Patent Box (sometimes also - more properly - defined as the Innovation Box since it is not all about patents ). The first modification that was proposed concerned the system of the tax incentive.

Designs 70

Designs Design Patent IP 70

43(B)log

FEBRUARY 24, 2021

Maryland: First ever digital advertising tax, on gross receipts. NY, DC, WA are considering similar taxes so it’s a trend to watch. Covid enforcement Steinman: FTC recorded more than 130,000 complaints in first half of 2020; issued more than 300 warning letters with 95% compliance rate; has brought some cases against covid treatments.

Advertising 40

Advertising Advertising Law Privacy 40

LexBlog IP

APRIL 15, 2022

The standard for art auctions, for example, covers a wide range of topics, ranging from lots collection to catalogue compilation, from industry terminology to best practices for auctioneers. Challenges: exchange control and tax. However, taxes presents an even bigger challenge. The regulation of galleries is even less strict.

Art 52

Art Marketing Marketing Artwork 52

Technology & Marketing Law Blog

JUNE 22, 2023

Instead, the CJPA takes an asinine, ineffective, unconstitutional, and industry-captured approach to this critical topic. This policy approach is sometimes called a “link tax,” but that’s a misnomer. For more on this topic, see Ashutosh A. The CJPA is none of that. is not foreign-owned, terrorist-owned, etc.

Journalism 88

Journalism Social Media Publishing Government 88

The IPKat

SEPTEMBER 12, 2022

This is the first in-person Congress since London hosted in 2019, so it was only apt that the first panel session was on the topic of IP and Covid-19. Wolf returned to the IP incentivization topic, but noted there was also the important “access” to vaccine issue. The production that was contracted out rose, but at a lesser rate.

Reporting 91

Reporting IP Contracts Licensing 91

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., For example, on April 2021, Representatives Paul D. Sandoz Inc.

Litigation 52

Litigation Settlement Patent Marketing 52